Tore Amundsen

Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Bjørn Henning Grønberg, Roy M. Bremnes, Øystein Fløtten et al. · Journal of Clinical Oncology · 2009 · 289 citations · Full text

Cancer Quality, Gemcitabine Plus Carboplatin, Cancer Management +17

Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer

Guro B. Stene, Jorunn L. Helbostad, Tore Amundsen et al. · Acta Oncologica · 2014 · 211 citations · Full text

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy

Bjørn Henning Grønberg, Stein Sundstrøm, Stein Kaasa et al. · European Journal of Cancer · 2010 · 117 citations

Oncology, Health-related Quality, Cancer Management +6

Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling

Kristine Pettersen, Sonja Andersen, Simone Degen et al. · Scientific Reports · 2017 · 112 citations · Full text

Pulmonary embolism: detection with MR perfusion imaging of lung--a feasibility study.

Tore Amundsen, Robert A. Jones, Anders Waage et al. · Radiology · 1997 · 98 citations